Damle; Nitin K.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Damle; Nitin K..The latest application filed is for "protein-polymer-drug conjugates".
Company Profile
3.23.19
- Damle; Nitin K. - Berwyn PA
- DAMLE; Nitin K. - Upper Saddle River NJ
- Damle; Nitin K. - Monmouth Junction NJ
- Damle; Nitin K. - Monmount Junction NJ
- Damle; Nitin K. - Upper Saddle Rive NJ
- Damle; Nitin K. - Renton WA
- Damle, Nitin K. - Hopewell NJ
- Damle; Nitin K. - Monmont Junction NJ
- Damle; Nitin K. - Bellevue WA
Patent Activity
| Patent | Date |
|---|---|
| Protein-polymer-drug conjugates Grant 11,434,278 - Smith , et al. September 6, 2 | 2022-09-06 |
| Protein-polymer-drug Conjugates App 20190241649 - Smith; Roger A. ; et al. | 2019-08-08 |
| Protein-polymer-drug conjugates Grant 10,316,080 - Smith , et al. | 2019-06-11 |
| Anti-5t4 Antibodies And Uses Thereof App 20180162937 - BOGHAERT; Erwin R. ; et al. | 2018-06-14 |
| Anti-5T4 antibodies and uses thereof Grant 9,902,771 - Boghaert , et al. February 27, 2 | 2018-02-27 |
| Anti-5t4 Antibodies And Uses Thereof App 20160185859 - BOGHAERT; Erwin R. ; et al. | 2016-06-30 |
| Protein-polymer-drug Conjugates App 20150125474 - Smith; Roger A. ; et al. | 2015-05-07 |
| Anti-5t4 Antibodies And Uses Thereof App 20140308302 - BOGHAERT; Erwin R. ; et al. | 2014-10-16 |
| Anti-5T4 antibodies and uses thereof Grant 8,759,495 - Boghaert , et al. June 24, 2 | 2014-06-24 |
| Therapeutic Compositions And Methods App 20120121505 - Gill; Davinder Singh ; et al. | 2012-05-17 |
| Anti-5t4 Antibodies And Uses Thereof App 20120064600 - BOGHAERT; Erwin R. ; et al. | 2012-03-15 |
| Anti-5T4 antibodies and uses thereof Grant 8,044,178 - Boghaert , et al. October 25, 2 | 2011-10-25 |
| Anti-cd20 Therapeutic Compositions And Methods App 20100330089 - Damle; Nitin K. ; et al. | 2010-12-30 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100173382 - Boghaert; Erwin R. ; et al. | 2010-07-08 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100021483 - BOGHAERT; ERWIN R. ; et al. | 2010-01-28 |
| Soluble CTLA4 mutant molecules and uses thereof App 20090317397 - Linsley; Peter S. ; et al. | 2009-12-24 |
| Therapeutic compositions and methods App 20090304590 - Gill; Davinder Singh ; et al. | 2009-12-10 |
| Soluble CTLA4 mutant molecules Grant 7,572,772 - Linsley , et al. August 11, 2 | 2009-08-11 |
| CTLA4 molecules and IL4-binding molecules and uses thereof App 20080031876 - Linsley; Peter S. ; et al. | 2008-02-07 |
| Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions Grant 7,311,910 - Linsley , et al. December 25, 2 | 2007-12-25 |
| Anti-5t4 Antibodies And Uses Thereof App 20070231333 - BOGHAERT; Erwin R. ; et al. | 2007-10-04 |
| Interleukin-11 compositions and methods of use App 20070160577 - Damle; Nitin K. ; et al. | 2007-07-12 |
| Methods Of Determining Pharmacokinetics Of Targeted Therapies App 20070003559 - Khandke; Kiran ; et al. | 2007-01-04 |
| Methods for blocking binding of CD28 receptor to B7 Grant 7,070,776 - Linsley , et al. July 4, 2 | 2006-07-04 |
| Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates App 20060088522 - Boghaert; Erwin R. ; et al. | 2006-04-27 |
| CTLA4 molecules and IL4-binding molecules and uses thereof App 20050169919 - Linsley, Peter S. ; et al. | 2005-08-04 |
| Method to inhibit T cell interactions with soluble B7 Grant 6,887,471 - Linsley , et al. May 3, 2 | 2005-05-03 |
| Method for generating and identifying antibodies directed against a B7 Grant 6,830,937 - Linsley , et al. December 14, 2 | 2004-12-14 |
| Ligand for CD28 receptor on B cells and methods App 20030219446 - Linsley, Peter S. ; et al. | 2003-11-27 |
| Method of regulating cellular processes mediated by B7 and CD28 Grant 6,641,809 - Linsley , et al. November 4, 2 | 2003-11-04 |
| CTLA4 receptor and uses thereof Grant 5,977,318 - Linsley , et al. November 2, 1 | 1999-11-02 |
| CTLA4 receptor and uses thereof Grant 5,968,510 - Linsley , et al. October 19, 1 | 1999-10-19 |
| CTLA4 receptor and uses thereof Grant 5,885,579 - Linsley , et al. March 23, 1 | 1999-03-23 |
| CTLA4 receptor and uses thereof Grant 5,885,796 - Linsley , et al. March 23, 1 | 1999-03-23 |
| Soluble CTLA4 molecules and uses thereof Grant 5,851,795 - Linsley , et al. December 22, 1 | 1998-12-22 |
| CTLA4 Ig fusion proteins Grant 5,844,095 - Linsley , et al. December 1, 1 | 1998-12-01 |
| Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules Grant 5,770,197 - Linsley , et al. June 23, 1 | 1998-06-23 |
| Mixed specificity fusion proteins Grant 5,709,859 - Aruffo , et al. January 20, 1 | 1998-01-20 |
| B7IG fusion protein Grant 5,580,756 - Linsley , et al. December 3, 1 | 1996-12-03 |
| CD28IG fusion protein Grant 5,521,288 - Linsley , et al. May 28, 1 | 1996-05-28 |
| Chimeric CTLA4 receptor and methods for its use Grant 5,434,131 - Linsley , et al. July 18, 1 | 1995-07-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 